Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016.

ABSTRACT:

Background

Infants younger than 6 months are at increased risk of complications and mortality from pertussis infection. In October 2012, the Advisory Committee on Immunization Practices revised its recommendation to include a Tdap dose during each pregnancy, ideally between 27 and 36 weeks gestation.

Objective

Assess trends in Tdap vaccination coverage among privately insured pregnant women from 2009 to 2016 including timing of Tdap vaccination (before, during, or after pregnancy), trimester of vaccination for women vaccinated during pregnancy, and missed vaccination opportunities for unvaccinated women. Identify factors associated with vaccination during the optimal period of 27-36 weeks gestation.

Study design

Retrospective analysis of privately insured women 15-49 

SUBMITTER: Zhou F 

PROVIDER: S-EPMC6557580 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature